Over half a million bottles of the blood pressure medication prazosin have been recalled nationwide by Teva Pharmaceuticals and Amerisource Health Services due to concerns it may contain potentially cancer-causing nitrosamine impurities, as announced by the FDA.
The U.S. Food and Drug Administration (FDA) has reported that drugmakers have recalled more than 580,000 bottles of the blood pressure medication prazosin hydrochloride. New Jersey-based Teva Pharmaceuticals USA and drugs distributor Amerisource Health Services issued voluntary nationwide recalls earlier this month for various strengths of prazosin capsules. Doctors prescribe prazosin to relax blood vessels and lower blood pressure, and it is also used for nightmares and sleep disturbances associated with post-traumatic stress disorder (PTSD). The FDA assigned a Class II risk classification to the affected lots, stating that some of the recalled medication may contain nitrosamine impurities, which are considered potentially cancer-causing chemicals that can form during manufacturing or storage.
